Susquehanna International Group
PVCT

Susquehanna International Group’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Susquehanna International Group’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-19,161
Closed -$7K – 10209
2015
Q4 		$7K Buy
+19,161
New +$9.08K ﹤0.01% 9314
2015
Q3 		– Sell
-2,453,100
Closed -$1.32M – 10709
2015
Q2 		$1.32M Buy
+2,453,100
New +$2M ﹤0.01% 5587
2015
Q1 		– Sell
-29,277
Closed -$23K – 10379
2014
Q4 		$23K Buy
+29,277
New +$26.8K ﹤0.01% 9476

Other funds holding PVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
HFBOT
Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Susquehanna International Group's PVCT Position: Q1 2016 in Review

Susquehanna International Group sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q1 2016, closing a stake of 19,161 shares — an estimated $7K sold.

Susquehanna International Group first reported a position in PVCT in Q4 2014 and held it in 3 quarters. The position peaked at $1.32M in Q2 2015. 44 funds tracked by Wall St. Rank hold PVCT as of Q1 2016.

  • Susquehanna International Group reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q1 2016 after selling out during the quarter.
  • Susquehanna International Group sold 19,161 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q1 2016, an estimated $7K.
  • Susquehanna International Group first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2014 and held it in 3 quarters.
  • Susquehanna International Group's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $1.32M in Q2 2015.
  • 44 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q1 2016.

Based on Susquehanna International Group's 13F filing for Q1 2016, filed 13 May 2016.